IL70445A - Substituted 4,7-dihydro-1h-pyrazolo(3,4-b)pyridine-5-carboxylic acid esters,their preparation and pharmaceutical compositions containing them - Google Patents

Substituted 4,7-dihydro-1h-pyrazolo(3,4-b)pyridine-5-carboxylic acid esters,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL70445A
IL70445A IL70445A IL7044583A IL70445A IL 70445 A IL70445 A IL 70445A IL 70445 A IL70445 A IL 70445A IL 7044583 A IL7044583 A IL 7044583A IL 70445 A IL70445 A IL 70445A
Authority
IL
Israel
Prior art keywords
pyrazolo
dihydro
pharmaceutical compositions
compositions containing
pyridine
Prior art date
Application number
IL70445A
Other languages
English (en)
Other versions
IL70445A0 (en
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of IL70445A0 publication Critical patent/IL70445A0/xx
Publication of IL70445A publication Critical patent/IL70445A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL70445A 1982-12-20 1983-12-14 Substituted 4,7-dihydro-1h-pyrazolo(3,4-b)pyridine-5-carboxylic acid esters,their preparation and pharmaceutical compositions containing them IL70445A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8236131 1982-12-20

Publications (2)

Publication Number Publication Date
IL70445A0 IL70445A0 (en) 1984-03-30
IL70445A true IL70445A (en) 1988-12-30

Family

ID=10535093

Family Applications (1)

Application Number Title Priority Date Filing Date
IL70445A IL70445A (en) 1982-12-20 1983-12-14 Substituted 4,7-dihydro-1h-pyrazolo(3,4-b)pyridine-5-carboxylic acid esters,their preparation and pharmaceutical compositions containing them

Country Status (19)

Country Link
US (1) US4954508A (es)
EP (1) EP0114273B1 (es)
JP (1) JPH0660181B2 (es)
KR (1) KR890002227B1 (es)
AT (1) ATE69227T1 (es)
AU (1) AU574654B2 (es)
DE (1) DE3382452D1 (es)
DK (1) DK582083A (es)
ES (2) ES8601987A1 (es)
FI (1) FI76337C (es)
GR (1) GR79111B (es)
IE (1) IE57305B1 (es)
IL (1) IL70445A (es)
MY (1) MY101250A (es)
NO (1) NO160367C (es)
NZ (1) NZ206626A (es)
PH (1) PH20896A (es)
PT (1) PT77850B (es)
ZA (1) ZA839092B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5965089A (ja) * 1982-10-05 1984-04-13 Shionogi & Co Ltd ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法
JPS60197685A (ja) * 1984-03-19 1985-10-07 Shionogi & Co Ltd ４，７―ジヒドロピラゾロ［３，４―ｂ］ピリジン誘導体とその製造法
US4873334A (en) * 1982-10-05 1989-10-10 Shionogi & Co., Ltd. 4,7-dihydropyrazolo(3,4-b) pyridine derivatives
JPS6056979A (ja) * 1983-09-08 1985-04-02 Shionogi & Co Ltd ４，７−ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法
US4918074A (en) * 1984-03-12 1990-04-17 Yoshitomi Pharmaceutical Industries, Ltd. Polyazaheterocycle compounds
US4916140A (en) * 1988-09-28 1990-04-10 Merrell Dow Pharmaceuticals Inc. Antiepileptic pyrazolopyridines
WO2002062795A2 (en) * 2001-02-02 2002-08-15 Mitsubishi Pharma Corporation Dihydropyrazolopyridine compounds and pharmaceutical use thereof
US6977262B2 (en) 2001-02-02 2005-12-20 Mitsubishi Pharma Corporation Dihydropyrazolopyridine compounds and pharmaceutical use thereof
AU2004264834A1 (en) * 2003-06-13 2005-02-24 Zentaris Gmbh Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773778A (en) * 1972-01-24 1973-11-20 Squibb & Sons Inc Sulfur derivatives of pyrazolo (3,4-b)pyridines
DE2356684A1 (de) * 1972-11-15 1974-05-16 Heyden Chem Fab Neue 4-aminoderivate von pyrazolo (3,4-b)pyridin-5-carboxamiden
US4038283A (en) * 1975-04-30 1977-07-26 E. R. Squibb & Sons, Inc. 4-Alkoxy or hydroxy derivatives of 2H-pyrazolo[3,4-b]pyridine-5-carboxylic acids and esters
GB1568399A (en) * 1975-10-16 1980-05-29 Squibb & Sons Inc Pyrazolo pyridine derivatives
US4020072A (en) * 1976-05-04 1977-04-26 E. R. Squibb & Sons, Inc. 5-Aminomethyl-1H-pyrazolo[3,4-b]pyridines
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
JPS5965089A (ja) * 1982-10-05 1984-04-13 Shionogi & Co Ltd ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法

Also Published As

Publication number Publication date
NZ206626A (en) 1986-11-12
FI76337B (fi) 1988-06-30
AU2227083A (en) 1984-06-28
IE57305B1 (en) 1992-07-15
EP0114273A1 (en) 1984-08-01
PT77850A (en) 1984-01-01
KR890002227B1 (ko) 1989-06-24
ES532124A0 (es) 1985-06-16
DE3382452D1 (de) 1991-12-12
ATE69227T1 (de) 1991-11-15
NO834695L (no) 1984-06-21
PH20896A (en) 1987-05-27
IL70445A0 (en) 1984-03-30
FI834661A (fi) 1984-06-21
FI834661A0 (fi) 1983-12-19
JPS59118786A (ja) 1984-07-09
JPH0660181B2 (ja) 1994-08-10
GR79111B (es) 1984-10-02
US4954508A (en) 1990-09-04
ZA839092B (en) 1984-07-25
NO160367C (no) 1989-04-12
DK582083A (da) 1984-06-21
NO160367B (no) 1989-01-02
PT77850B (en) 1986-05-08
MY101250A (en) 1991-08-17
FI76337C (fi) 1988-10-10
EP0114273B1 (en) 1991-11-06
ES528152A0 (es) 1985-11-16
KR840007000A (ko) 1984-12-04
DK582083D0 (da) 1983-12-16
IE832988L (en) 1984-06-20
ES8601987A1 (es) 1985-11-16
ES8506016A1 (es) 1985-06-16
AU574654B2 (en) 1988-07-14

Similar Documents

Publication Publication Date Title
ES8603477A1 (es) Procedimiento para preparar una 1h-imidazo (4, 5-c) quinolin-4-amina
HUT46699A (en) Process for producing phosphinic acid derivatives and pharmaceutical compositions containing them as active components
ES8503685A1 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
PT86433A (en) Process for the preparation of thiol-carboxylic acid derivatives
EP0487986A3 (en) Process for the preparation of esters of (6s)-6,8-dihydroxyoctanoic acid
IL70445A (en) Substituted 4,7-dihydro-1h-pyrazolo(3,4-b)pyridine-5-carboxylic acid esters,their preparation and pharmaceutical compositions containing them
IL53757A (en) Imidazo(1,2-a)quinoline-2-carboxylic acids,their esters and salts,process for preparing them and pharmaceutical compositions containing them
CS274612B2 (en) Method of substituted 1,3,4,9-tetrahydropyrano (3,4-b) indol-1-acetic acids production
ES8701177A1 (es) Procedimiento para preparar derivados de pirazol-(1,5a)piri-dina
HUT45398A (en) Process for production of lyophilized medical compositions containing derivatives of phenil-quinoline-carbonic acid
EP0284969A3 (en) Process for the preparation of tetrahydropyran-4-carboxylic acid esters
AR240674A1 (es) Procedimiento para la preparacion de derivados del acido fenil-2-imidazo(1,2-a)quinoleinacetico y sus sales
HUT49055A (en) Process for producing inhalant pharmaceutical composition comprising pyrazolo(1,5-a) pyridine derivative as active ingredient
DE2964718D1 (en) Process for the preparation of 7-oxabicyclo(4.1.0)heptane-3,4-dicarboxylic acid diglycidyl ester
PT86143A (en) Process for the preparation of guanidinomethylbenzoic acid derivatives
HUT47579A (en) Process for production of new imidazo /1,2-a/-pirimidins and their salts and medical compositions containing them as active substance
DE2964538D1 (en) Process for the preparation of 7-oxabicyclo(4.1.0)heptane-3,4-dicarboxylic acid diglycidyl ester
PT72710A (en) Process for the preparation of imidazo/4,5-b/pyridine derivatives useful as cardiotonics
YU95583A (en) Process for making condensed cycloaliphatic derivatives of substituted pyrido (1,2-a)pyrimidines
EG18418A (en) Process for the preparation of novel 2-thienyloxacetic acid derivatives
YU83284A (en) Process for making 2-alkylthio-1aminoalkyl-2-pyroline-3-carbonitrile
HRP940853B1 (en) Process for the preparation of new thienyloxyactic acid derivatives
HRP950049B1 (en) Process for the preparation of new benzimidazoline-2oxo-1-carboxylic acid derivatives
YU81790A (en) Process for preparing compositions of substituted propan-phosphinic acids
CS646489A2 (en) Method of substituted 1,3,4,9-tetrahydropyrano (3,4-b) iniole-acetic acids production